The search for the cause and cure for Alzheimer's

  • Dayan B. Goodenowe, PhD

Circulating plasmalogen level and Alzheimer disease assessment scale

  • Paul L. Wood, PhD; Rishikesh Mankidy, PhD; Shawn Ritchie, PhD; Doug Heath, MSc; Julie A. Wood, MD; John Flax, MD; Dayan B. Goodenowe, PhD

APOE genotype, plasmalogens and post-mortem pathology

  • Dayan Goodenowe, Mahsa Naseri, Vijitha Senanayake

APOE genotype, serum plasmalogens, cognition and mortality

  • Dayan Goodenowe, Mahsa Naseri, Vijitha Senanayake

Plasmalogen deficiency and neuropathology in Alzheimer’s Disease: causation or coincidence?

  • Vijitha Senanayake, PhD, Dr. Dayan B. Goodenowe, PhD

Relation of serum plasmalogens and APOE genotype to cognition and dementia in older persons

  • Dayan B. Goodenowe, PhD

The effect of APOE genotype, plasmalogen biosynthesis and reverse cholesterol transport biomarkers on cognition and odds of Alzheimers disease in elderly persons

  • Dayan Goodenowe, Tara Smith, Vijitha Senanayake, Bassirou Chitou, Asuka Mochizuki, Sue E. Leurgans, David A. Bennett

Peripheral ethanolamine plasmalogen deficiency - a logical causative factor in Alzheimers disease and dementia

  • Dayan B. Goodenowe, Lisa L. Cook, Jun Liu, Yingshen Lu, Dushmanthi A. Jayasinghe, Pearson W. K. Ahiahonu, Doug Heath, Yasuyo Yamazaki, John Flax, Kevin F. Krenitsky, D. L. Sparks, Alan Lerner, Robert P. Friedland, Takashi Kudo, Kouzin Kamino, Takashi Morihara, Masatoshi Takeda, and Paul L. Wood

An integrated metabolomic model of the six most consistent biochemical system dysfunctions observed in AD

The Alzheimer’s Metabolome

Indices of plasmalogen biosynthesis in ADNI- 1 baseline serum samples

Membrane Plasmalogen and Cholesterol Regulation - a structure activity study

  • Rishikesh Mankidy, Pearson WK Ahiahonu, Hong Ma, Dushmanthi Jayasinghe, Shawn A Ritchie, Mohamed A Khan, Khine K Su-Myat, Paul L Wood and Dayan B Goodenowe

Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice

  • Edith Miville-Godbout1, Mélanie Bourque, Marc Morissette, Sara Al-Sweidi, Tara Smith, Asuka Mochizuki, Vijitha Senanayake, Dushmanthi Jayasinghe, Li Wang, Dayan Goodenowe, Thérèse Di Paolo

Peripheral ethanolamine plasmalogen def - a logical causative factor in Alzheimer's disease and dementia

  • Dayan B. Goodenowe 1, Lisa L. Cook, Jun Liu, Yingshen Lu, Dushmanthi A. Jayasinghe, Pearson W. K. Ahiahonu, Doug Heath, Yasuyo Yamazaki, John Flax, Kevin F. Krenitsky, D. L. Sparks, Alan Lerner, Robert P. Friedland, Takashi Kudo, Kouzin Kamino, Takashi Morihara, Masatoshi Takeda and Paul L. Wood †††

Alzheimers Disease Pathogenesis Core concepts, shifting paradigms and therapeutic targets

  • Paul L. Wood, M. Amin Khan, Rishikesh Mankidy, Tara Smith and Dayan B. Goodenowe

Plasmalogens and AD Scientific Summary

Oral bioavailability of the ether lipid plasmalogen precursor in rabbit_therapetuc strategy for Alzheimers disease

  • Paul L Wood1, Tara Smith, Nina Lane, M Amin Khan, Greg Ehrmantraut and Dayan B Goodenowe

Relation of Serum Plasmaloges, APOE4, Dementia

  • Vijitha Senanayake, PhD, Dr. Dayan B. Goodenowe, PhD

Plasmalogen Deficit - A New and Testable Hypothesis for the Etiology of Alzheimer's Disease

  • Paul L. Wood, M. Amin Khan, Rishikesh Mankidy, Tara Smith and Dayan B. Goodenowe